Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Event details are collected in one workspace.
GALT
$3.64
+0.55%
GALT
· Galectin Therapeutics Inc
$3.64
+0.02 (+0.55%)
At close · Oct 8
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$366.08M
Shares
100.85M
Volume · Oct 8
270.89K
Avg daily vol (3M)
384.17K
All webcasts
Investor Update · 2026-03-10
Galectin Therapeutics Inc (GALT) March 2026 Investor Update
Research coverage
0 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.